and the Bayer Cross was used as the trademark for all of the I.G.'s pharmaceutical products. In the early 1930s, the Wupperal-Elberfeld facility continued its successful research into drugs to ...
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.
Bayer AG faces a $100 million jury verdict over PCB exposure at a Seattle school amid ongoing legal challenges related to ...
Hosted on MSN22d
Bayer attacked bureaucracy by firing some 5,000 managers and asking teams to ‘self-organize.’ Here’s how it’s going after one yearSo I was intrigued to read last year about the radical plan to attack bureaucracy at German pharma company Bayer. The company ... and our products.” But little changes, he ventured, would ...
Meanwhile, Bayer's Pharmaceutical division has delivered ... This growth was driven by significant gains from new products, with Nubeqa and Kerendia achieving growth rates of 83.2% and 96.4% ...
In a bold move to restore $540 million in cost savings, Bayer CEO Bill Anderson cut out ... teams with a clearer focused on our customers and products,” Hayes shares. Anderson’s push for ...
( MENAFN - GlobeNewsWire - Nasdaq) Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback